INVIVYD, INC.
1601 Trapelo Road, Suite 178
Waltham, MA 02451
October 3, 2022
VIA EDGAR
Office of Life Sciences
Division of Corporation Finance
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attn: Daniel Crawford
| Re: | Invivyd, Inc. |
Registration Statement on Form S-3
Filed September 28, 2022
File No. 333-267643
Request for Acceleration of Effective Date
Dear Mr. Crawford:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Invivyd, Inc. hereby requests that the Securities and Exchange Commission accelerate the effective date of the above-referenced Registration Statement on Form S-3 and declare such Registration Statement effective as of 4:00 p.m., Eastern Time, on October 5, 2022, or as soon thereafter as possible.
Please direct any questions or comments concerning this request to Stephen M. Nicolai of Hogan Lovells US LLP at (267) 675-4642. Also, please notify Mr. Nicolai when this request for acceleration has been granted.
| Very truly yours, | ||
| INVIVYD, INC. | ||
| By: | /s/ Jill Andersen | |
| Name: | Jill Andersen | |
| Title: | Chief Legal Officer and Corporate Secretary | |